Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
- REP-GB-7078
- 2018-07-19
- Category: Healthcare, Pharmaceuticals and Medical devices
- 187 Pages
- Format:
Pneumococcal disease is an infection caused by streptococcus pneumonia. Pneumococcal infection can result in pneumonia, bacteremic pneumonia, bacteremia, meningitis, bloodstream infection and middle ear infection. There are two main types of pneumococcal diseases, namely non-invasive and invasive pneumococcal diseases. Invasive pneumococcal diseases, such as bacteremia (sepsis), meningitis and bacteremic pneumonia, tend to be more serious compared to non-invasive. Serotypes 1, 4, 5, 7F, 8, 12F, 14, 18C, and 19A are more likely to cause invasive pneumococcal diseases.
According to the World Health Organization, pneumonia accounted for 16% deaths of children aged under 5 year in 2015. Pneumococcal vaccines are used against streptococcus pneumonia. There are 2 types of pneumococcal vaccines available—conjugate vaccines and polysaccharide vaccines. The WHO has recommended pneumococcal conjugate vaccines in the routine immunization for children. In this report, the pneumococcal vaccines market is further categorized into product type and distribution channel. The report provides market size and forecast for pneumococcal vaccines against streptococcus pneumonia, inclusive of both types of vaccines. The report analyses the demand for pneumococcal vaccines form pharmacies, public health agencies, community clinics and other distribution channels.
Market Value and Forecast
In terms of revenue, the global pneumococcal vaccines market is projected to expand at 9.1% CAGR over the forecast period of 2018–2028. The pneumococcal vaccines market is expected to be valued at US$ 18,456.5 Mn by 2028 end. The addition of pneumococcal vaccine national immunization programs and development of new pneumococcal vaccines are expected to boost the growth of the global pneumococcal vaccines market over the forecast period. According to the World Health Organization, pneumococcal vaccines were added in the national immunization programs of 138 countries till 2017.
Market Dynamics
The global demand for pneumococcal vaccines is growing as a result of increasing initiatives by government and private organizations to provide vaccination in developing countries. Public–private partnerships to provide low-cost pneumococcal vaccines in middle-income countries is also expected to propel the growth of the pneumococcal vaccines market. Pneumococcal vaccines are introduced in more than 57 Gavi-supported countries under the advance market commitment. Development of pneumococcal vaccines for all age groups is expected to create favourable growth opportunities for the pneumococcal vaccines market. Likewise, increasing awareness among parents regarding vaccination, catch up champignons to reduce IPD risk and partnerships & funding for development of new vaccines are expected to boost the growth of the global pneumococcal vaccines market. However, low immunization coverage for new pneumococcal vaccines, slow introduction of vaccines in middle-income countries, low awareness among older population regarding pneumococcal vaccination are some of the factors expected to hamper the growth of the pneumococcal vaccines market.
Key Regions
Geographically, the global pneumococcal vaccines market is segmented into seven major regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (Asia-Pacific excluding Japan), Japan and the Middle East & Africa (MEA). In terms of value, North America was the dominant regional market for pneumococcal vaccines in 2017 and is expected to expand at high CAGR of 10.2% over the forecast period of 2018–2028. Asia Pacific is expected to contribute significant revenue share in the global pneumococcal vaccine market due to increasing government funding and the addition of pneumococcal vaccines in national immunization programs in the region.
Key Players
Examples of some of the key players identified in the global pneumococcal vaccines market are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., and Merck & Co., Inc., among others. Manufacturers are focusing on research and development activities to develop multivalent pneumococcal vaccines. Pfizer Inc. and GlaxoSmithKline Plc. have collaborated with Gavi vaccine alliance to supply their pneumococcal vaccines in Gavi-supported countries. Through this collaboration, both the companies have increased their presence in the market and contribute to the immunization program.
Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market. The primary objective of the report is to offer updates and information related to opportunities in the global pneumococcal vaccines market.
Report Description
In terms of revenue, the global pneumococcal vaccines market is expected to register a CAGR of 9.1% during the forecast period of 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global pneumococcal vaccines market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.
The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate. Pneumonia is the leading cause of child deaths. 16% of all deaths under age 5 are due to pneumonia. The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market. Besides, the support from Gavi to low-income countries for pneumococcal immunization is expected to boost the growth of the pneumococcal vaccines market. Availability of cost-effective vaccines in developing countries as well as favourable reimbursement policies for pneumococcal conjugate and polysaccharide vaccine are expected to spur the demand for pneumococcal vaccines.
Research & development activities for the development of new pneumococcal vaccines, balanced supply and demand, government and private funding for pneumococcal vaccines are expected to boost the demand for pneumococcal vaccines over the forecast period. Manufacturers are focusing on mergers and collaborations for the development of new vaccines, whereas increasing pharmacy-based pneumococcal immunization is expected to create huge opportunities for growth of the pneumococcal vaccines market.
The revenue of the pneumococcal vaccines market in North America is expected to grow at the high rate. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and distribution channel. The report provides analysis of the global pneumococcal vaccines market in terms of market value (US$ Mn).
The report begins with the market definition, followed by definitions of the different pneumococcal vaccines types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global pneumococcal vaccines market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights
The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:
-
North America
-
U.S.
-
Canada
-
-
Latin America
-
Brazil
-
Mexico
-
Rest of Latin America
-
-
Western Europe
-
Germany
-
Italy
-
France
-
Spain
-
U.K.
-
Rest of Western Europe
-
-
Eastern Europe
-
Russia
-
Poland
-
Rest of Eastern Europe
-
-
Asia Pacific Excluding Japan
-
India
-
China
-
ASEAN
-
Australia & New Zealand
-
Rest of APEJ
-
-
Japan
-
Middle East & Africa (MEA)
-
GCC Countries
-
South Africa
-
Rest of MEA
-
The next section provides competitive edge of the global pneumococcal vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the pneumococcal vaccines market. The competition landscape section provides dashboard view of the activities of major players in the global pneumococcal vaccines market. The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc.
The next section analyses the market on the basis of product type and presents the forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:
-
Pneumococcal Polysaccharide Vaccines
-
Pneumococcal Conjugate Vaccines
The next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years. The distribution channels covered in the report include:
-
Pharmacies
-
Community Clinics
-
Public Health Agencies
-
Others
In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global pneumococcal vaccines market.
Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by pneumococcal vaccines market. To understand the key segments in terms of their growth and performance in the global pneumococcal vaccines market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.
Pneumococcal Vaccines Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Pneumococcal Vaccines Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Key Trends
5. Key Inclusions
5.1. Disease Epidemiology
5.2. Reimbursement Scenario
5.3. Pipeline Assessment
6. Respiratory Syncytial Virus (RSV) Vaccines Market, Pipeline Assessment
7. North America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
7.4.1. Pneumococcal Conjugate Vaccines
7.4.2. Pneumococcal Polysaccharide Vaccines
7.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.6.1. Pharmacies
7.6.2. Community Clinics
7.6.3. Public Health Agencies
7.6.4. Others
7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Product
7.8.3. By Distribution Channel
7.9. Key Market Participants – Intensity Mapping
8. Latin America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Country, 2013–2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
8.4.1. Pneumococcal Conjugate Vaccines
8.4.2. Pneumococcal Polysaccharide Vaccines
8.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.6.1. Pharmacies
8.6.2. Community Clinics
8.6.3. Public Health Agencies
8.6.4. Others
8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Product
8.8.3. By Distribution Channel
8.9. Key Market Participants – Intensity Mapping
9. Western Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By Country, 2013–2017
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Spain
9.2.5. Italy
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
9.4.1. Pneumococcal Conjugate Vaccines
9.4.2. Pneumococcal Polysaccharide Vaccines
9.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.6.1. Pharmacies
9.6.2. Community Clinics
9.6.3. Public Health Agencies
9.6.4. Others
9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Product
9.8.3. By Distribution Channel
9.9. Key Market Participants – Intensity Mapping
10. Eastern Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) By Country, 2013–2017
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
10.4.1. Pneumococcal Conjugate Vaccines
10.4.2. Pneumococcal Polysaccharide Vaccines
10.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.6.1. Pharmacies
10.6.2. Community Clinics
10.6.3. Public Health Agencies
10.6.4. Others
10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
10.8. Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Product
10.8.3. By Distribution Channel
10.9. Key Market Participants – Intensity Mapping
11. Asia Pacific excluding Japan and China (APEJ) Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) By Country, 2013–2017
11.2.1. India
11.2.2. China
11.2.3. Australia and New Zealand
11.2.4. ASEAN
11.2.5. Rest of APEJ
11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
11.4.1. Pneumococcal Conjugate Vaccines
11.4.2. Pneumococcal Polysaccharide Vaccines
11.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.6.1. Pharmacies
11.6.2. Community Clinics
11.6.3. Public Health Agencies
11.6.4. Others
11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
11.8. Market Attractiveness Analysis
11.8.1. By Country
11.8.2. By Product
11.8.3. By Distribution Channel
11.9. Key Market Participants – Intensity Mapping
12. Japan Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
12.2.1. Pneumococcal Conjugate Vaccines
12.2.2. Pneumococcal Polysaccharide Vaccines
12.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.4.1. Pharmacies
12.4.2. Community Clinics
12.4.3. Public Health Agencies
12.4.4. Others
12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.7. Key Market Participants – Intensity Mapping
13. MEA Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Market Size (US$ Mn) Forecast By Country, 2018–2028
13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
13.3.1. Pneumococcal Conjugate Vaccines
13.3.2. Pneumococcal Polysaccharide Vaccines
13.4. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
13.5.1. Pharmacies
13.5.2. Community Clinics
13.5.3. Public Health Agencies
13.5.4. Others
13.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
13.7. Market Attractiveness Analysis
13.7.1. By Country
13.7.2. By Product
13.7.3. By Distribution Channel
13.8. Key Market Participants – Intensity Mapping
14. Forecast Factors: Relevance and Impact
15. Drivers and Restraints: Impact Analysis
16. Macroeconomic Assumptions
17. Market Share Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Company Deep Dive
18.2.1. Pfizer Inc.
18.2.1.1. Overview
18.2.1.2. Product Portfolio
18.2.1.3. Production Footprint
18.2.1.4. Sales Footprint
18.2.1.5. Strategy
18.2.1.5.1. Marketing Strategy
18.2.1.5.2. Product Strategy
18.2.1.5.3. Channel Strategy
18.2.2. Merck & Co., Inc.
18.2.2.1. Overview
18.2.2.2. Product Portfolio
18.2.2.3. Production Footprint
18.2.2.4. Sales Footprint
18.2.2.5. Strategy
18.2.2.5.1. Marketing Strategy
18.2.2.5.2. Product Strategy
18.2.2.5.3. Channel Strategy
18.2.3. GlaxoSmithKline plc.
18.2.3.1. Overview
18.2.3.2. Product Portfolio
18.2.3.3. Production Footprint
18.2.3.4. Sales Footprint
18.2.3.5. Strategy
18.2.3.5.1. Marketing Strategy
18.2.3.5.2. Product Strategy
18.2.3.5.3. Channel Strategy
18.2.4. Sanofi SA
18.2.4.1. Overview
18.2.4.2. Product Portfolio
18.2.4.3. Production Footprint
18.2.4.4. Sales Footprint
18.2.4.5. Strategy
18.2.4.5.1. Marketing Strategy
18.2.4.5.2. Product Strategy
18.2.4.5.3. Channel Strategy
19. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
19.2.1. North America
19.2.2. Western Europe
19.2.3. Eastern Europe
19.2.4. Latin America
19.2.5. Asia Pacific excluding Japan
19.2.6. Japan
19.2.7. Middle East and Africa
19.3. Market Size (US$ Mn) Forecast By Region, 2018–2028
19.4. Market Attractiveness Analysis By Region
20. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Product
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
20.2.1. Pneumococcal Conjugate Vaccines
20.2.2. Pneumococcal Polysaccharide Vaccines
20.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
20.4. Market Attractiveness Analysis By Product Type
21. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
21.2.1. Pharmacies
21.2.2. Community Clinics
21.2.3. Public Health Agencies
21.2.4. Others
21.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
21.4. Market Attractiveness Analysis By Distribution Channel
22. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028
22.1. Market Value Share Analysis
22.1.1. By Country
22.1.2. By Product
22.1.3. By Distribution Channel
22.2. Y-o-Y Growth Analysis
22.2.1. By Country
22.2.2. By Product
22.2.3. By Distribution Channel
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms
24. Research Methodology
Pneumococcal Vaccines Market Reports - List of Tables
Table 1a: Factors Considered While Setting Vaccine Prices, By Company
Table 1b: Factors Considered While Setting Vaccine Prices, By Company
Table 02a: Pneumococcal Vaccines Market Pipeline Analysis (2017)
Table 02b: Pneumococcal Vaccines Market Pipeline Analysis (2017)
Table 02c: Pneumococcal Vaccines Market Pipeline Analysis (2017)
Table 02d: Pneumococcal Vaccines Market Pipeline Analysis (2017)
Table 03a: RSV Vaccines Market Pipeline Analysis (2017)
Table 03b: RSV Vaccines Market Pipeline Analysis (2017)
Table 03c: RSV Vaccines Market Pipeline Analysis (2017)
Table 03d: RSV Vaccines Market Pipeline Analysis (2017)
Table 03e: RSV Vaccines Market Pipeline Analysis (2017)
Table 03f: RSV Vaccines Market Pipeline Analysis (2017)
Table 04: North America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 05: North America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 06: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 07: Latin America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 08: Latin America Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 09: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 10: Western Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 11: Western Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 12: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 13: Eastern Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 14: Eastern Europe Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 15: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 16: APEJ Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 17: APEJ Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 18: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 19: Japan Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 20: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 21: MEA Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Country
Table 22: MEA Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 23: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Table 24: Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast By Region, 2013–2028
Table 25: Global Pneumococcal Vaccines Market size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Product Type
Table 26: Global Pneumococcal Vaccines Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Distribution Channel
Pneumococcal Vaccines Market Reports - List of Figures
Figure 01: Market Size (US$ Mn) by Region (2017A & 2028F)
Figure 02: Global Pneumococcal Vaccines Market Value Share By Product Type 2017 (A)
Figure 03: Global Pneumococcal Vaccines Market Value Share By Product Type 2017 (A)
Figure 04: Tiered-price Policies Among Vaccine Manufacturers
Figure 05: Pneumococcal Vaccine Procured Volumes 2010-2017 (in millions of doses)
Figure 06: Countries Approved for Gavi's Pneumococcal Vaccine Support-
Figure 07: Trends in Invasive Pneumococcal Diseases Among Children Aged <5 year Old, 1998–2016
Figure 08: Summary of AMC Financial Process Flow And Funds Disbursed in Private-public Partnerships (Inception to 31 December 2017)
Figure 09: Countries With Pneumococcal Conjugate Vaccine in The National Immunization Program and Planned Introductions (In 2018)
Figure 10: Global Coverage of Older Vaccines vs. Newer Vaccines (2016)
Figure 11: Comparison of PCV Uptake in High-income, Gavi-eligible and Gavi-ineligible Countries, 2010–2016
Figure 12: Number of Children Who Were Unvaccinated, By Country
Figure 13: Distribution of Industry Sponsored Clinical Programs for Pneumococcal Vaccines, by Phase
Figure 14: Distribution of Industry Sponsored Clinical Programs for Pneumococcal Vaccines, by Age Group
Figure 15: Geographical Distribution of Clinical Trials for Pneumococcal Vaccines (2017)
Figure 16: Distribution of Industry Sponsored Clinical Programs for RSV Vaccines, by Phase
Figure 17: Distribution of Industry Sponsored Clinical Programs for RSV Vaccines, by Age Group
Figure 18: Geographical Distribution of Clinical Trials for RSV Vaccines (2017)
Figure 19: North America Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 20: North America Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 21: North America Pneumococcal Vaccines Market Split By Country (2018)
Figure 22: North America Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 23: North America Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 24: U.S. Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 25: U.S. Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 26: Canada Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 27: Canada Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 28: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 29: North America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 30: North America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 31: North America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 32: North America Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 33: North America Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 34: North America Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 35: Latin America Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 36: Latin America Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 37: Latin America Pneumococcal Vaccines Market Split By Country (2018)
Figure 38: Latin America Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 39: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 40: Brazil Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Brazil Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 42: Mexico Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: Mexico Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 44: Rest of Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 45: Rest of Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 46: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 47: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 48: Latin America Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 49: Latin America Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 50: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 51: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 52: Latin America Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 53: Western Europe Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 54: Western Europe Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 55: Western Europe Pneumococcal Vaccines Market Split By Country (2018)
Figure 56: Western Europe Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 57: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 58: U.K. Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 59: U.K. Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 60: France Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 61: France Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 62: Germany Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 63: Germany Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 64: Italy Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 65: Italy Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 66: Spain Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 67: Spain Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 68: Rest of Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 69: Rest of Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 70: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 71: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 72: Western Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 73: Western Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 74: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 75: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 76: Western Europe Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 77: Eastern Europe Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 78: Eastern Europe Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 79: Eastern Europe Pneumococcal Vaccines Market Split By Country (2018)
Figure 80: Eastern Europe Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 81: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 82: Russia Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 83: Russia Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 84: Poland Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 85: Poland Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 86: Rest of Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 87: Rest of Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 88: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 89: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 90: Eastern Europe Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 91: Eastern Europe Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 92: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 93: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 94: Eastern Europe Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 95: APEJ Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 96: APEJ Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 97: APEJ Pneumococcal Vaccines Market Split By Country (2018)
Figure 98: APEJ Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 99: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 100: India Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: India Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 102: Australia & New Zealand Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 104: China Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: China Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 106: ASEAN Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 107: ASEAN Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 108: Rest of APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 109: Rest of APEJ Australia & New Zealand Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 110: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 111: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 112: APEJ Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 113: APEJ Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 114: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 115: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 116: APEJ Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 117: Japan Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 118: Japan Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 119: Japan Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 120: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 121: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 122: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 123: Japan Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 124: Japan Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 125: Japan Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 126: Japan Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 127: MEA Pneumococcal Vaccines Market Split By Product Type (2018)
Figure 128: MEA Pneumococcal Vaccines Market Split By Distribution Channel (2018)
Figure 129: MEA Pneumococcal Vaccines Market Split By Country (2018)
Figure 130: MEA Pneumococcal Vaccines Market Size Analysis, 2013–2017
Figure 131: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y growth, 2018–2028
Figure 132: South Africa Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 133: South Africa Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 134: GCC Countries Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 135: GCC Countries Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 136: Rest of MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017
Figure 137: Rest of MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 138: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Polysaccharide Vaccines
Figure 139: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Polysaccharide Vaccines
Figure 140: MEA Pneumococcal Vaccines Market Size (US$ Mn) Analysis, 2013–2017, By Pneumococcal Conjugate Vaccines
Figure 141: MEA Pneumococcal Vaccines Market Forecast & Y-o-Y Growth (%), 2018–2028, By Pneumococcal Conjugate Vaccines
Figure 142: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 143: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 144: MEA Pneumococcal Vaccines Market Attractiveness Analysis By Country, 2018–2028
Figure 145 : Global Pneumococcal Vaccines Market Share Analysis (%) By Region, 2018 & 2028
Figure 146: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Region, 2018–2028
Figure 147: Global Pneumococcal Vaccines Market Attractiveness Analysis By Region, 2018–2028
Figure 148: Global Pneumococcal Vaccines Market Share Analysis (%) By Product Type, 2018 & 2028
Figure 149: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Product Type, 2018–2028
Figure 150: Global Pneumococcal Vaccines Market Attractiveness Analysis By Product Type, 2018–2028
Figure 151: Global Pneumococcal Vaccines Share Analysis (%) By Distribution Channel, 2018 & 2028
Figure 152: Global Pneumococcal Vaccines Market Y-o-Y Growth (%) By Distribution Channel, 2018–2028
Figure 153: Global Pneumococcal Vaccines Market Attractiveness Analysis By distribution channel , 2018–2028
Figure 154: Global Pneumococcal Vaccines Market Value Analysis and Forecast, 2017–2028 (US$ Mn)
Figure 155: Global Pneumococcal Vaccines Market Absolute $ Opportunity (US$ Mn), 2017–2028